INS and metabolic dysfunction-associated steatotic liver disease: Therefore, we tested an additional classification where only insulin secretion failure—strongly reflected by 2 h glucose—was defined as a high-risk phenotype and all subjects with normal insulin secretion—including those with insulin-resistant NAFLD—were considered as low risk (model 2).